InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（10 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
10
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Ragusa Robert P, 董事. Officer active across 3 companies, notably Twist Bioscience Corp. Aggregated, 19 disclosures have been published. Breakdown: 0 buy · 10 sells. Total volume traded: €13.4m. History available since 8 February 2022. The latest transaction was disclosed on 1 September 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ragusa Robert P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
5,686 股0Common StockSEC:0001222644-26-000004:0
123,502 股@ US$49.917627.9% 占其流量Common StockSEC:0001628280-26-024550:0
980 股@ US$53.010.2% 占其流量Common StockSEC:0001628280-26-016216:0
35,787 股@ US$50.08536.9% 占其流量Common StockSEC:0001628280-26-014311:0
5,095 股0Common StockSEC:0001214659-26-001343:0
14,807 股@ US$94.43165.8% 占其流量Common StockSEC:0001628280-25-055599:0
7,239 股@ US$68.882.2% 占其流量Common StockSEC:0001628280-25-045269:0
94,035 股@ US$33.9320.7% 占其流量Common StockSEC:0001699031-25-000099:0
7,625 股@ US$31.211.6% 占其流量Common StockSEC:0001699031-25-000066:0
7,625 股@ US$31.211.6% 占其流量Common StockSEC:0001699031-25-000059:0
994 股@ US$41.510.3% 占其流量Common StockSEC:0001699031-25-000049:0
4,472 股0Common StockSEC:0001214659-25-002231:0
224,620 股@ US$28.8446.3% 占其流量Common StockSEC:0001699031-25-000008:0
123,454 股@ US$14.0211.6% 占其流量Common StockSEC:0001628280-24-043069:0
214,240 股@ US$12.5717.9% 占其流量Common StockSEC:0001628280-24-042471:0
475,178 股0Common StockSEC:0001628280-24-030869:0
5,815 股0Common StockSEC:0001214659-24-002247:0
8,212 股0Common StockSEC:0001214659-23-001882:0
3,491 股0Common StockSEC:0001214659-22-002206:0
19 条申报中的 19 条
About Ragusa Robert P
Robert P. Ragusa is an Administrateur. He has filed 18 disclosures in total, and across the recent filings available between 2022-02-10 and 2026-04-09, the transactions are sales, with EUR 13,380,653 in sales and EUR 0 in purchases. The filings concern GRAIL, Inc., where he is Chief Executive Officer, and Twist Bioscience Corp, where he is Director.
